Project Grant R21CA318809
Award Date 8/14/26
Completion Date 7/31/28
Dollars Obligated $399K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48201, USA
Similar Awards
- The National Cancer Institute awarded Regents of the University of Michigan $785,278 on August 14, 2026, under the Cancer Treatment Research program (CFDA 93.395) to develop and evaluate the efficacy of the MI Sleep Coach App, a mobile cognitive behavioral therapy for insomnia (CBT-I) intervention designed specifically for cancer survivors. Sleep disturbances affect over 50 percent of breast, prostate, and colorectal cancer survivors and are associated with negative effects on physical and...
- The National Cancer Institute awarded Massachusetts General Hospital $225,360 on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop and pilot test SLEEPCARE, a multimodal telehealth behavioral intervention designed to reduce sleep disturbance in caregivers of patients with primary malignant brain tumors. The five-year project, running through August 31, 2031, addresses a gap in clinical care: approximately 55 percent of caregivers in this population experience...
- The National Cancer Institute awarded $321,097 to Baylor College of Medicine on July 6, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to develop and pilot-test a telehealth-delivered cognitive-behavioral therapy protocol for insomnia in children receiving maintenance therapy for acute lymphoblastic leukemia. The award funds the Resolving Sleep Troubles in Childhood Leukemia (REST) project, which adapts evidence-based cognitive-behavioral therapy for pediatric...
- The National Cancer Institute, a division of the Department of Health and Human Services National Institutes of Health, awarded Health Research, Inc. (Roswell Park Division) $446,112 on July 3, 2026, under the Cancer Biology Research program (CFDA 93.396) to identify age-regulating breast cancer dormancy genes using C. elegans dauer models. The project investigates how chronological aging of dormant cancer cells drives metastatic relapse and reawakening after initial treatment. The recipient...
- The National Institutes of Health National Cancer Institute awarded Wayne State University $155,000 on May 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to investigate multi-level predictors of diagnostic follow-up attendance after an abnormal cervical cancer screen. The project will identify individual-level and clinic-level barriers and facilitators to diagnostic follow-up completion among women who receive abnormal cervical cancer screening results. Current...
- Grant Award Summary The National Cancer Institute (NCI) awarded the University of Virginia a $3.36 million Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) on September 24, 2025, to evaluate the efficacy of accessible and scalable digital interventions for addressing co-occurring insomnia and depression in breast cancer survivors. The project, which extends through August 31, 2029, will conduct a randomized controlled trial comparing Shuti (a...
- The National Cancer Institute awarded Michigan State University (Henry Ford Health+Michigan State University Health Sciences) $185,881 on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to conduct a pilot trial testing digital strategies to increase patient-reported outcome (PRO) assessment completion among cancer patients. The funded research, titled "Promoting Patient Reporting of Outcome Measures Through Technology Integrated Self-Management and Engagement...
- The National Cancer Institute awarded Sloan-Kettering Institute for Cancer Research $745,458 on July 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to develop and test a digital intervention that uses patient portals to improve person-centered communication between cancer patients and oncology clinicians. The PERSON intervention comprises three automated, scalable components: a portal-enabled assessment tool (a 14-item questionnaire capturing patient information...
- The National Cancer Institute awarded the University of Southern California $680,452 on June 9, 2026, under the Cancer Treatment Research program (CFDA 93.395) to discover and develop novel small-molecule compounds that selectively target the circadian regulatory complex BMAL1:CLOCK for cancer therapeutics. The recipient will execute a large-scale high-throughput screening campaign to identify small molecules that modulate BMAL1 and CLOCK proteins, building on a prior pilot screen that yielded...
- The National Cancer Institute awarded Michigan State University Henry Ford Health+Michigan State University Health Sciences $309,874 on September 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop and test a fully asynchronous digital intervention for reducing alcohol misuse in adolescent and young adult cancer survivors. The project adapts TRAC-AYA (Tracking and Reducing Alcohol Consumption in AYAs), a technology-based intervention previously developed...